Skip to main content
Smart Investors Daily
SW

NASDAQ · SWKHL

SWK Holdings Corporation 9.00% Senior Notes due 2027

Financial Services · Asset Management

$25.21

Up+$0.03 (+0.12%)

Updated Nov 4, 2026, 8:52 PM

SID Score

4.6/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
180.59M
P/E ratio
12.18
Dividend yield
8.93%
52-week range
$24.34 – $25.79
Volume
2.33K
Avg. volume
2.82K

Price performance · SWKHL

SWKHL price history

1M range · 19 trading sessions · Daily adjusted prices

Prices through Nov 2, 2026

SWKHL closed at $25.21 after 19 trading sessions, up 0.54% for the selected period.

Last close
$25.21
Period change
+0.54%
Period low
$25.07
Period high
$25.21
Daily close
View OHLC price history
SWKHL OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 2, 2026$25.18$25.21$25.18$25.212.33K
Oct 30, 2026$25.17$25.1802$25.17$25.18026.3K
Oct 29, 2026$25.16$25.175$25.16$25.1757.61K
Oct 28, 2026$25.17$25.1799$25.16$25.17992.59K
Oct 27, 2026$25.15$25.1796$25.15$25.17967.23K
Oct 26, 2026$25.15$25.17$25.15$25.1653.81K
Oct 23, 2026$25.14$25.17$25.14$25.1654.35K
Oct 22, 2026$25.1301$25.135$25.1301$25.135499
Oct 21, 2026$25.12$25.14$25.12$25.13014.43K
Oct 19, 2026$25.135$25.135$25.13$25.13015.71K
Oct 16, 2026$25.146$25.146$25.146$25.146323
Oct 15, 2026$25.10$25.12$25.10$25.121.66K
Oct 14, 2026$25.14$25.14$25.11$25.11014.23K
Oct 13, 2026$25.13$25.13$25.11$25.1115.49K
Oct 12, 2026$25.11$25.1101$25.11$25.1101533
Oct 9, 2026$25.10$25.10$25.095$25.0952.04K
Oct 8, 2026$25.07$25.0739$25.07$25.07392.47K
Oct 7, 2026$25.09$25.09$25.07$25.075.67K
Oct 6, 2026$25.055$25.099$25.04$25.0757.2K

Latest SWKHL news

The latest Smart Investors Daily articles mentioning SWKHL.

SWKHL research

Overview

Company profile and research snapshot.

Company profile

SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Further, it intends to out-license its internal product pipeline to create novel formulations using its proprietary technology to develop treatments for patients and caregivers. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.